IMMUNOGENICITY AND SAFETY OF INACTIVATED INFLUENZA VIRUS VACCINE IN YOUNG CHILDREN IN 2003–2004


    loading  Checking for direct PDF access through Ovid

Abstract

This study assessed the safety and immunogenicity of a pediatric formulation of the 2003–2004 inactivated, trivalent, split virion influenza vaccine, administered in a 2-dose schedule in healthy children ages 6–36 months, of whom 94% had protective titers (≥1/40) to at least 1 antigen. The 2003–2004 split virion influenza vaccine was safe and immunogenic in young children.

    loading  Loading Related Articles